Today, rfxcel is proud to announce new members to the rfxcel’s Board of Directors: Walmart's EVP of Logistics and Amgen's SVP of Quality. These leaders are known for contributing to the
International provider of SaaS-based track and trace and serialisation solutions, rfxcel, today announces its continued successful expansion in the UK and EMEA
Connecting to national traceability systems has proven to be more complex than originally planned. Read more what Mark Davison, Head of EU for rfxcel, and other leaders say about the DSCSA & FMD
rfxcel announced today that it will pay the cost of statutory fees payable to EMVO for all manufacturers (Marketing Authorisation Holders, MAHs) which select rfxcel as their Gateway Provider before
rfxcel announced today that they will expand their capability to enable LATAM Life Science(s) organizations to meet serialization and regulatory compliance requirements throughout Latin America and
rfxcel now has fully integrated “edge” functionality for warehouse, distribution and re-work operations (Warehouse Edge System).
March 6, 2018 - San Ramon, CA - rfxcel, the world’s leader in supply chain track and trace for the Pharmaceutical industry is one of two companies recognized by the HDA (Healthcare Distribution
Pharmaceuticals and medical devices provider DCC Vital chooses rfxcel, a Pharma track and trace company, as Falsified Medicines Directive and Serialisation Solution Provider.
rfxcel, the leader in Life Science track and trace, and compliance systems, today announced the release of rfxcel Traceability System (rTS) 6.0. The new traceability software delivers increased
rfxcel, a global Track & Trace company, has been confirmed as a Technically Certified Connection Provider by the European Medicines Verification Organization (EMVO).
As part of rfxcel’s continued commitment to serve its global customers, rfxcel is pleased to announce that key leaders in track and trace join rfxcel Executive Team to drive global growth.
rfxcel, the world’s leader in supply chain track and trace for the Pharmaceutical industry is pleased to announce the acquisition of assets from Frequentz, Inc., a leading player in life science
Global pharmaceutical safety through smart serialization and open collaboration. The need for pharmaceutical companies to have absolute and accurate visibility of their supply chains is imperative.
rfxcel will expand its capability to enable Life Sciences companies to meet serialization and regulatory compliance needs in the European territories.
San Ramon, CA – August 3, 2017- rfXcel, the leader in Track and Trace and regulatory compliance solutions, today announces it has raised $30 million in a round of funding led by Kayne Partners.